ALIGOS THERAPEUTICS

Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). Aligos’ strategy is to harness the deep expertise and decades of drug development experience its workforce has in liver disease, particularly viral hepatitis, to rapidly advance its pipeline of potentially best-in-class molecules.

#SimilarOrganizations #People #Financial #Website #More

ALIGOS THERAPEUTICS

Social Links:

Facebook

Linkedin

Twitter

Industry:

Biotechnology

Founded:

2018-04-12

Address:

San Francisco, California, United States

Country:

United States

Website Url:

http://www.aligos.com

Total Employee:

101+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

308.6 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics

Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

Current Employees Featured

lawrence-blatt_image

Lawrence Blatt
Lawrence Blatt Chief Executive Officer & Founder @ Aligos Therapeutics
Chief Executive Officer & Founder
2018-03-01

not_available_image

Leonid Beigelman
Leonid Beigelman President and Founder @ Aligos Therapeutics
President and Founder

not_available_image

Meenakshisundaram Venkatraman
Meenakshisundaram Venkatraman Senior Director, CMC @ Aligos Therapeutics
Senior Director, CMC
2020-01-01

Founder

lawrence-blatt_image

Lawrence Blatt

not_available_image

Leonid Beigelman

Stock Details

Company's stock symbol is NASDAQ:ALGS

Investors List

janus-henderson-investors_image

Janus Henderson Investors

Janus Henderson Investors investment in Series B - Aligos Therapeutics

vivo-capital_image

Vivo Capital

Vivo Capital investment in Series B - Aligos Therapeutics

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series B - Aligos Therapeutics

logos-capital_image

Logos Capital

Logos Capital investment in Series B - Aligos Therapeutics

roche-venture-fund_image

Roche Venture Fund

Roche Venture Fund investment in Series B - Aligos Therapeutics

pivotal-bioventure-partners_image

Pivotal bioVenture Partners

Pivotal bioVenture Partners investment in Series B - Aligos Therapeutics

versant-ventures_image

Versant Ventures

Versant Ventures investment in Series B - Aligos Therapeutics

boxer-capital_image

Boxer Capital

Boxer Capital investment in Series B - Aligos Therapeutics

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series B - Aligos Therapeutics

wellington-management_image

Wellington Management

Wellington Management investment in Series B - Aligos Therapeutics

Official Site Inspections

http://www.aligos.com Semrush global rank: 4.9 M Semrush visits lastest month: 1.78 K

Host Informations
Whois Informations

Loading ...

More informations about "Aligos Therapeutics" on Search Engine